top of page
colab.oratory
CART
PRECISION MEDICINE
CRISIS TO CATALYST
BIOSIMILARS
COLAB.CONVERSATIONS
colabXchange
precision medicine think tank
co.laterals
co.llective
colab
co(ntext)
colab(orate)
co(mmentary)
we are not here to fit in
HOME
co(ntext)
colab.oratory
CART
PRECISION MEDICINE
precision medicine think tank
CRISIS TO CATALYST
PATIENT CENTRIC APPROACH TO HTA
COLAB.CONVERSATIONS
co.laterals
co.llective
co(mmentary)
colab(orate)
DESIGNED FOR
SYSTEMS CHANGE
the cancer collaborative
is a catalyst for change — where disruptive ideas and creative strategy come together to challenge systems, influence policy, and drive real impact for people affected by cancer.
All Posts
science
policy
advocacy
Search
Ontario introduces biosimilars switching policy
Jan 24, 2023
2 min read
improving access to innovative therapies
Nov 17, 2020
1 min read
biosimilars can significantly reshape access to innovative cancer therapies
Feb 7, 2020
0 min read
canadian institute for health information [CIHI] publishes drug spending statistics
Jan 13, 2020
1 min read
biosimilars are not just a cost saving opportunity but the opportunity to create a more sustainable
Aug 29, 2019
2 min read
biosimilars. the european experience
Jun 21, 2019
3 min read
biosimilars. past talk to action
May 30, 2019
2 min read
colab.oratory
CART
PRECISION MEDICINE
CRISIS TO CATALYST
BIOSIMILARS
COLAB.CONVERSATIONS
colabXchange
precision medicine think tank
co.laterals
co.llective
co(ntext)
colab(orate)
co(mmentary)
CO
LAB
bottom of page